Jenny Desantis

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Room Temperature

Top Venues

Organic & biomolecular chemistry

Journal of medicinal chemistry

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Venturi, Stefano Di Bona, Jenny Desantis, Michela Eleuteri, Matteo Bartalucci, Massimo Baroni, Paolo Benedetti, Laura Goracci, Gabriele Cruciani
Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs. Journal of medicinal chemistry (2024)
Michela Eleuteri, Jenny Desantis, Gabriele Cruciani, Raimondo Germani, Laura Goracci
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis. Organic & biomolecular chemistry 22 (17) (2024)
Michela Eleuteri, Jenny Desantis, Gabriele Cruciani, Raimondo Germani, Laura Goracci
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis. Organic & biomolecular chemistry 22 (17) (2024)
Michela Eleuteri, Jenny Desantis, Gabriele Cruciani, Raimondo Germani, Laura Goracci
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis. Organic & biomolecular chemistry 22 (17) (2024)
Michela Eleuteri, Jenny Desantis, Gabriele Cruciani, Raimondo Germani, Laura Goracci
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis. Organic & biomolecular chemistry (2024)
Michela Eleuteri, Jenny Desantis, Gabriele Cruciani, Raimondo Germani, Laura Goracci
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis. Organic & biomolecular chemistry 22 (17) (2024)
Michela Eleuteri, Jenny Desantis, Gabriele Cruciani, Raimondo Germani, Laura Goracci
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis. Organic & biomolecular chemistry 22 (17) (2024)
Stefano Bonciarelli, Jenny Desantis, Simone Cerquiglini, Laura Goracci
MassChemSite for In-Depth Forced Degradation Analysis of PARP Inhibitors Olaparib, Rucaparib, and Niraparib. ACS omega 8 (7) (2023)
Beatrice Castellani, Michela Eleuteri, Stefano Di Bona, Gabriele Cruciani, Jenny Desantis, Laura Goracci
VHL-Modified PROteolysis TArgeting Chimeras (PROTACs) as a Strategy to Evade Metabolic Degradation in In Vitro Applications. Journal of medicinal chemistry (2023)
Stefano Bonciarelli, Jenny Desantis, Simone Cerquiglini, Laura Goracci
MassChemSite for In-Depth Forced Degradation Analysis of PARP Inhibitors Olaparib, Rucaparib, and Niraparib. ACS omega 8 (7) (2023)
Jenny Desantis, Andrea Mammoli, Michela Eleuteri, Alice Coletti, Federico Croci, Antonio Macchiarulo, Laura Goracci
PROTACs bearing piperazine-containing linkers: what effect on their protonation state? RSC advances 12 (34) (2022)
Tommaso Palomba, Giusy Tassone, Carmine Vacca, Matteo Bartalucci, Aurora Valeri, Cecilia Pozzi, Simon Cross, Lydia Siragusa, Jenny Desantis
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design. International journal of molecular sciences 23 (22) (2022)
Jenny Desantis, Laura Goracci
Proteolysis targeting chimeras in antiviral research. Future medicinal chemistry 14 (7) (2022)
Stefano Bonciarelli, Jenny Desantis, Laura Goracci, Lydia Siragusa, Ismael Zamora, Elisabeth Ortega-Carrasco
Automatic Identification of Lansoprazole Degradants under Stress Conditions by LC-HRMS with MassChemSite and WebChembase. Journal of chemical information and modeling 61 (6) (2021)
Serena Massari, Jenny Desantis, Maria Giulia Nizi, Violetta Cecchetti, Oriana Tabarrini
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions. ACS infectious diseases 7 (6) (2020)
Laura Goracci, Jenny Desantis, Aurora Valeri, Beatrice Castellani, Michela Eleuteri, Gabriele Cruciani
Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications. Journal of medicinal chemistry 63 (20) (2020)
Geun Taek Lee, Naoya Nagaya, Jenny Desantis, Kiran Madura, Hatem E Sabaawy, Isaac Yi Kim, Roy J Vaz, Gabriele Cruciani
Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7 and Androgen Receptor, on CRPC Resistant to Second-Line Antiandrogen Therapy. Molecular cancer therapeutics 20 (3) (2020)